Having shown that Rnpc3 heterozygosity limits the growth of liver, lung and gastric hyperplasia/adenomas, we investigated whether hyperproliferative blood cancers were sensitive to Rnpc3 expression as well. The gene discussed is RNPC3; the disease is hematopoietic and lymphoid system neoplasm.